Articles Vol. 65 No. CĐ 3 - Bệnh viện Phổi Trung ương 15/05/2024

10. A CLINICAL CASE OF AUDIO TOXICOLOGY RELATED TO MACROLID ANTIBIOTIC FROM NATIONAL LUNG HOSPITAL IN 2021

Nguyen Thi Thuy1,2, Dinh Thu Huong1,2
1 National Lung Hospital
2 Bệnh viện Phổi Trung ương
Corresponding author: Huongdinhbvp@gmail.com
DOI: 10.52163/yhc.v65iCD3.1105
14 Views
9 Downloads
Keywords
Macrolide, Azithromycin, auditory, NTM.
Abstract

Audio ototoxicity refers to the damage with the inner structures of the ear (cochlea and vestibule) and their functions (hearing and balance) that can be experienced with exposure to certain drugs (eg, aminoside antibiotics, cisplatin, macrolides, etc.). Aminoside-associated ototoxicity is common to the doctor but hasn't been recognized and noticed with macrolide. We report a case of a patient presenting with tinnitus and hearing loss when using macrolide antibiotics for a long time in the treatment of NTM.

References
[1]
Barbieri MA, Cicala G, Cutroneo PM et al., Google Scholar
[2]
Ototoxic adverse drug reactions: A disproportionality Google Scholar
[3]
analysis using the Italian spontaneous reporting Google Scholar
[4]
database, Front Pharmacol, 2019. Google Scholar
[5]
Ikeda AK, Prince AA, Chen JX et al., "Macrolide- Google Scholar
[6]
associated sensorineural hearing loss: Google Scholar
[7]
A systematic review", Laryngoscope. (2018) Google Scholar
[8]
:228–36. Google Scholar
[9]
Anna V, Berthe CO, Nelly FL et al., Macrolide- Google Scholar
[10]
associated ototoxicity: A cross-sectional Google Scholar
[11]
and longitudinal study to assess the association Google Scholar
[12]
of macrolide use with tinnitus and hearing loss, Google Scholar
[13]
Journal of Antimicrobial Chemotherapy. 76, Google Scholar
[14]
, pp. 2708–2716. Google Scholar
[15]
Barbieri MA, Cicala G, Cutroneo PM et al., Google Scholar
[16]
Ototoxic adverse drug reactions: A disproportionality Google Scholar
[17]
analysis using the Italian spontaneous Google Scholar
[18]
reporting database, Front Pharmacol. 10:1161. Google Scholar
[19]
3389/fphar.2019.01161, 2019. Google Scholar
[20]
Brown BA, Griffith DE, Girard W et al., Relationship Google Scholar
[21]
of adverse events to serum drug levels Google Scholar
[22]
in patients receiving high-dose azithromycin Google Scholar
[23]
for mycobacterial lung disease, Clin Infect Dis, Google Scholar
[24]
, 24:958–64. 10.1093/clinids/24.5.958 Google Scholar
[25]
Griffith DE, Brown BA, Girard WM et al., Google Scholar
[26]
Azithromycin activity against Mycobacterium avium Google Scholar
[27]
complex lung disease in patients who were Google Scholar
[28]
not infected with human immunodeficiency Google Scholar
[29]
virus", Clin Infect Dis(23:983–9. 10.1093/clinids/23.5.983), 1996. Google Scholar
[30]
Guay DR, Patterson DR, Seipman N et al., Google Scholar
[31]
Guay DR, Patterson DR, Seipman N, Craft JC. Google Scholar
[32]
Overview of the tolerability profile of clarithromycin Google Scholar
[33]
in preclinical and clinical trials.", Drug Saf. (1993) Google Scholar
[34]
:350–64. 10.2165/00002018-199308050-00003. Google Scholar
[35]
McGhan LJ, Merchant SN, Erythromycin Google Scholar
[36]
ototoxicity, Otol Neurotol, pp. 24:701–2. Google Scholar
[37]
1097/00129492-200307000-00029, 2003. Google Scholar
[38]
Pawlowski KS, Si E, Wright CG et al., Ototoxicity Google Scholar
[39]
of topical azithromycin solutions in the Google Scholar
[40]
guinea pig, Arch Otolaryngol Head Neck Surg Google Scholar
[41]
:481–7. 10.1001/archoto.2010.54, 2010. Google Scholar
[42]
Tseng AL, Dolovich L, Salit IE, Azithromycin- Google Scholar
[43]
related ototoxicity in patients infected with Google Scholar
[44]
human immunodeficiency virus, N Engl J Med. Google Scholar
[45]
:689–98.(10.1056/NEJMoa1104623), 2011. Google Scholar